Aprecia Pharms Drug Patent Portfolio
Aprecia Pharms owns 1 orange book drug protected by 5 US patents Given below is the list of Aprecia Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11160786 | Rapid disperse dosage form | 14 Mar, 2034 | Active |
| US9339489 | Rapid disperse dosage form containing levetiracetam | 14 Mar, 2034 | Active |
| US9669009 | Rapid disperse dosage form containing levetiracetam | 14 Mar, 2034 | Active |
| US6471992 | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same | 20 Feb, 2018 | Expired |
| US9463160 | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same | 20 Feb, 2018 | Expired |
Latest Legal Activities on Aprecia Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Aprecia Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Post Issue Communication - Certificate of Correction | 26 Jan, 2022 | US11160786 |
|
Recordation of Patent Grant Mailed
Critical
| 02 Nov, 2021 | US11160786 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 02 Nov, 2021 | US11160786 |
|
Email Notification
Critical
| 14 Oct, 2021 | US11160786 |
|
Issue Notification Mailed
Critical
| 13 Oct, 2021 | US11160786 |
| Dispatch to FDC | 01 Oct, 2021 | US11160786 |
|
Application Is Considered Ready for Issue
Critical
| 01 Oct, 2021 | US11160786 |
|
Issue Fee Payment Verified
Critical
| 28 Sep, 2021 | US11160786 |
|
Issue Fee Payment Received
Critical
| 28 Sep, 2021 | US11160786 |
|
Email Notification
Critical
| 01 Sep, 2021 | US11160786 |
|
Mail Notice of Allowance
Critical
| 01 Sep, 2021 | US11160786 |
|
Electronic Review
Critical
| 01 Sep, 2021 | US11160786 |
|
Notice of Allowance Data Verification Completed
Critical
| 30 Aug, 2021 | US11160786 |
| Interview Summary - Examiner Initiated - Telephonic | 26 Aug, 2021 | US11160786 |
| Appeal Brief Review Complete | 07 Jun, 2021 | US11160786 |
Aprecia Pharms's Family Patents
Aprecia Pharms Drug List
Given below is the complete list of Aprecia Pharms's drugs and the patents protecting them.
1. Spritam
Spritam is protected by 5 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11160786 | Rapid disperse dosage form |
14 Mar, 2034
(9 years from now)
| Active |
| US9339489 | Rapid disperse dosage form containing levetiracetam |
14 Mar, 2034
(9 years from now)
| Active |
| US9669009 | Rapid disperse dosage form containing levetiracetam |
14 Mar, 2034
(9 years from now)
| Active |
| US6471992 | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
20 Feb, 2018
(6 years ago)
| Expired |
| US9463160 | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
20 Feb, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Spritam's drug page